Hydroxycarbamide for very young children with sickle cell anaemia: No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)37-38
Number of pages2
JournalEvidence-Based Medicine
Volume17
Issue number2
DOIs
StatePublished - Apr 2012

Fingerprint

Sickle Cell Anemia
Spleen
Kidney
Pain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{81c32d86b4a748ccba204fa9a537917b,
title = "Hydroxycarbamide for very young children with sickle cell anaemia: No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity",
author = "Manwani, {Deepa G.}",
year = "2012",
month = "4",
doi = "10.1136/ebm.2011.100104",
language = "English (US)",
volume = "17",
pages = "37--38",
journal = "Evidence-Based Medicine",
issn = "1356-5524",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Hydroxycarbamide for very young children with sickle cell anaemia

T2 - No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity

AU - Manwani, Deepa G.

PY - 2012/4

Y1 - 2012/4

UR - http://www.scopus.com/inward/record.url?scp=84859445313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859445313&partnerID=8YFLogxK

U2 - 10.1136/ebm.2011.100104

DO - 10.1136/ebm.2011.100104

M3 - Article

C2 - 21891796

AN - SCOPUS:84859445313

VL - 17

SP - 37

EP - 38

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

SN - 1356-5524

IS - 2

ER -